Target Audience: This activity is designed for Nurses, Pharmacists, PAs, Physicians, and the Healthcare Team. This activity is accredited for Nurses, Pharmacists, PAs, Physicians, and the Healthcare Team.
Module Description: Fentanyl usage remains a critical public health concern in the US, contributing to alarming increases in overdose fatalities. Clinicians, patients, their families, and policymakers often find themselves uncertain about how to address this rapidly evolving landscape of illicit drug supply. This module aims to provide insights into extended-release injectable products and explore clinical strategies for effectively managing patients who use fentanyl.
Educational Objectives:
- Identify aspects of fentanyl pharmacology that complicate opioid use disorder (OUD) pharmacology.
- Review the data supporting the use of medications for treating patients using fentanyl, with an emphasis on extended-release injectable products.
- Discuss other clinical strategies for managing fentanyl-using patients.
Continuing Education information:
Accreditation Statement
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physicians
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Nurse Practitioners
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 CNE credits.
Pharmacists
This activity has been approved for 1 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers: JA4008192-0000-23-052-H01-P (pharmacy).
PAs
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 2/5/2027. PAs should only claim credit commensurate with the extent of their participation.
Other Health Professionals and Other Learners
Participants will receive a certificate stating this program is designated for 1 AMA PRA Category 1 Credits™. This credit is accepted by the AANP and the AAPA.
All Learners
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credits for learning and change.
